Glaucoma News

ST. LOUIS – Mohammed Rafieetary, OD, said he presented a case here at Optometry’s Meeting in which the Glaucoma Module Premium Edition of the Heidelberg Spectralis allowed him to determine that a myopic patient with a tilted disc did not have glaucoma.

Researchers found no evidence of a relationship between obstructive sleep apnea and primary open angle glaucoma.

Three randomized, multicenter, phase 2 studies demonstrated the efficacy and safety of omidenepag isopropyl as an alternative method to lower IOP, according to a study.

Carl Zeiss Meditec has invested in MicroOptx Inc., becoming a shareholder in the Minneapolis-based company, according to a press release.

KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, Nathan M. Radcliffe, MD, presents an overview of the latest advances in sustained glaucoma drug delivery platforms.

KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, Thomas W. Samuelson, MD, discusses the latest advancements in MIGS, reviewing the procedures through stage of disease and degree of disruption.

Researchers found a significant correlation between severe obstructive sleep apnea and a higher risk of structural deterioration in patients with glaucoma.

Patients treated with topical preservative-free tafluprost and timolol fixed-dose combination experienced a statistically and clinically significant IOP reduction, according to preliminary results of Santen’s real-world evidence VISIONARY study at the European Society of Ophthalmology congress.

The first subject has been dosed in a phase 1b trial of the primary open-angle glaucoma treatment candidate AKB-9778, according to a press release from Aerpio Pharmaceuticals.

ROME — Fewer drops are in the future of glaucoma treatment, according to one specialist speaking at the OSN Italy meeting. More laser and new injectable sustained-release devices will alleviate the burden of multiple daily medications, improving compliance and consistency of results.